Literature DB >> 33513661

Journal Club: Do Inhaled Corticosteroids Reduce All-Cause Mortality in Chronic Obstructive Pulmonary Disease? What is the Latest Evidence?

Ron Balkissoon1.   

Abstract

Entities:  

Keywords:  all-cause mortality; chronic obstructive pulmonary diseases; copd; inhaled corticosteroids

Year:  2021        PMID： 33513661      PMCID： PMC8047612          DOI： 10.15326/jcopdf.2020.0196

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN： 2372-952X


× No keyword cloud information.
  13 in total

1.  Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD.

Authors:  Brian J Lipworth; Chris R W Kuo
Journal:  Eur Respir J       Date:  2019-02-14       Impact factor: 16.671

2.  Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

Authors:  David A Lipson; Frank Barnhart; Noushin Brealey; Jean Brooks; Gerard J Criner; Nicola C Day; Mark T Dransfield; David M G Halpin; MeiLan K Han; C Elaine Jones; Sally Kilbride; Peter Lange; David A Lomas; Fernando J Martinez; Dave Singh; Maggie Tabberer; Robert A Wise; Steven J Pascoe
Journal:  N Engl J Med       Date:  2018-04-18       Impact factor: 91.245

3.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

4.  Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

Authors:  Jørgen Vestbo; Julie A Anderson; Robert D Brook; Peter M A Calverley; Bartolome R Celli; Courtney Crim; Fernando Martinez; Julie Yates; David E Newby
Journal:  Lancet       Date:  2016-04-28       Impact factor: 79.321

5.  The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Authors:  Jadwiga A Wedzicha; Peter M A Calverley; Terence A Seemungal; Gerry Hagan; Zainab Ansari; Robert A Stockley
Journal:  Am J Respir Crit Care Med       Date:  2007-10-04       Impact factor: 21.405

6.  Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease.

Authors:  Bartolome Celli; Marc Decramer; Steven Kesten; Dacheng Liu; Sunil Mehra; Donald P Tashkin
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

7.  Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  David A Lipson; Courtney Crim; Gerard J Criner; Nicola C Day; Mark T Dransfield; David M G Halpin; MeiLan K Han; C Elaine Jones; Sally Kilbride; Peter Lange; David A Lomas; Sally Lettis; Pamela Manchester; Neil Martin; Dawn Midwinter; Andrea Morris; Steven J Pascoe; Dave Singh; Robert A Wise; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

8.  Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis.

Authors:  Hyun Woo Lee; Jimyung Park; Junwoo Jo; Eun Jin Jang; Chang-Hoon Lee
Journal:  PLoS Med       Date:  2019-11-15       Impact factor: 11.069

9.  Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.

Authors:  Fernando J Martinez; Klaus F Rabe; Gary T Ferguson; Jadwiga A Wedzicha; Dave Singh; Chen Wang; Kimberly Rossman; Earl St Rose; Roopa Trivedi; Shaila Ballal; Patrick Darken; Magnus Aurivillius; Colin Reisner; Paul Dorinsky
Journal:  Am J Respir Crit Care Med       Date:  2021-03-01       Impact factor: 21.405

10.  "Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".

Authors:  Jose Gregorio Soto-Campos; Vicente Plaza; Joan B Soriano; Carlos Cabrera-López; Carlos Almonacid-Sánchez; Rosa Vazquez-Oliva; Jose Serrano; Aitor Ballaz-Quincoces; Alicia Padilla-Galo; Vanessa Santos
Journal:  BMC Pulm Med       Date:  2013-12-10       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.